Inspire Medical Systems Faces Investor Lawsuit Over Inspire V Launch
Inspire Medical Systems Inc. faces a class action lawsuit from investors over losses linked to the Inspire V launch. The lawsuit claims the company made false statements and concealed issues such as poor demand, inadequate training, and IT setup failures, contradicting public assurances of a successful launch. These alleged failures led to investor losses between August 2024 and August 2025.
A class action lawsuit has been filed against Inspire Medical Systems Inc. on behalf of investors who suffered losses between August 6, 2024, and August 4, 2025. The complaint alleges that the company made false statements and concealed critical information regarding the launch of its new product, Inspire V. Specifically, it is claimed that demand for Inspire V was poor due to providers having surplus inventory and reluctance to adopt the new treatment. Additionally, the company allegedly failed to complete essential tasks for the launch, such as training and onboarding treatment centers, setting up IT systems, updating insurer claims software, and ensuring Medicare reimbursement was in place. These failures, which contradicted the company’s public assurances of a successful launch, led to significant losses for investors. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Medical Systems Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1114631) on December 04, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
